Latest News From BioPharmaChem
01 August, 2019
It was announced yesterday that MSD will construct a new 13,000 square metre facility on a site adjacent to MSD’s existing Carlow plant. The facility will focus on the production of vaccines and biologics.It is scheduled to commence manufacturing operations in 2022 and will employ an additional 170 staff and 100 contractor staff when operational. The build phase will also see approximately 700 tradespeople employed on site.
05 August, 2019
Irish healthcare services company Uniphar said it had completed the acquisition of Durbin, a specialist supplier of pharmaceuticals based in the US and UK. Durbin, which supplies more than 160 countries, will be integrated into Uniphar’s Product Access division, growing the unit to more than 170 employees and managing access programmes for 36 global manufacturers, from offices in Ireland, the UK and the US.